EUVIMEDEUVIMED entdecken
Crossref

4-Adamantyl-(2-(arylidene)hydrazinyl)thiazoles As Potential Antidiabetic Agents: Experimental and Docking Studies

Yasir Iqbal, Tashfeen Akhtar iD, Muhammad Haroon iD, Hasnain Mehmood iD, Tauqir Nizami iD, Ehsaan Tahir iD, Muhammad Ehsan iD

Future Medicinal Chemistry · 2023

DOI: 10.4155/fmc-2023-0010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2023. Verfasst von Yasir Iqbal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Mirpur University of Science & Technology (MUST), 10250-Mirpur (AJK), Pakistan. Hauptthemen laut MEDLINE: Antioxidants, Thiazoles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To develop an efficient and cost-effective antidiabetic agent.

Methods

A simple and convenient Hantzsch synthetic strategy was used to prepare 4-adamantyl-(2-(arylidene)hydrazinyl)thiazoles.

Results

Fifteen newly established structures of 4-adamantyl-(2-(arylidene)hydrazinyl)thiazoles were tested for their α-amylase, antiglycation and antioxidant activities. Almost all tested compounds showed excellent α-amylase inhibition. Compounds 3a and 3j exhibited the highest potency, with IC50 values of 16.34 ± 2.67 and 16.64 ± 1.12 μM, respectively. Compounds 3c and 3i exhibited comparable antiglycation potential with the standard, aminoguanidine. The antioxidant potential of compound 3g was found to be excellent, with an IC50 value of 28.19 ± 0.2563 μM. The binding interactions of compound 3a (binding energy = -8.833 kcal/mol) with human pancreatic α-amylase identified 3a as a potent α-amylase inhibitor.

Conclusion

Enrichment of established structures with more electron-donating functionalities may assist/lead to the development of more potent antidiabetic drugs. Diabetes is one of the major causes of death in the present era. To combat damaging processes associated with diabetes, called glycation and oxidation, we prepared a series of compounds called 4-adamantyl-(2-(arylidene)hydrazinyl)thiazoles. The established structures were tested for their antidiabetic potential. The compounds 4-adamantyl-(2-(4-chlorobenzylidene)hydrazinyl)thiazole and 4-adamantyl-(2-(2-chlorobenzylidene)hydrazinyl)thiazole showed the highest potency. The compounds 4-adamantyl-(2-(4-bromobenzylidene)hydrazinyl)thiazole and 4-adamantyl-(2-(2-hydroxybenzylidene)hydrazinyl)thiazole exhibited comparable antiglycation potential. The antioxidant potential of compound 4-adamantyl-(2-(3-nitrobenzylidene)hydrazinyl)thiazole was found to be excellent. A further test was used to check toxicity and all compounds were found to be biocompatible. We also investigated, through docking studies, the way in which these compounds interact with the human proteins albumin and pancreatic α-amylase.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsThiazolesHumansMolecular Docking SimulationHypoglycemic Agentsalpha-AmylasesStructure-Activity Relationship

Stichwörter der Autor:innen

adamantaneantiglycationantioxidanthemolysismolecular dockingthiazolesα-amylase

Substanzen

AntioxidantsThiazolesHypoglycemic Agentsalpha-Amylases

Autor:innen und Institutionen

  • Department of Chemistry, Mirpur University of Science & Technology (MUST), 10250-Mirpur (AJK), Pakistan.
  • Department of Chemistry, Government Major Muhammad Afzal Khan (Shaheed), Boys Degree College Afzalpur (Affiliated with Mirpur University of Science & Technology (MUST), 10250-Mirpur (AJK), Pakistan.
  • Department of Chemistry and Biochemistry, Miami University, 651 E. High Street, Oxford, Ohio 45056, USA.
  • Deputy Director ORIC, University of Chakwal, Punjab, Pakistan.
  • Bionano-Chemistry Lab, Department of Bionano Engineering, Hanyang University, Ansan, 155-88, Korea.

ORCID-Profile: Tashfeen Akhtar, Muhammad Haroon, Hasnain Mehmood, Tauqir Nizami, Ehsaan Tahir, Muhammad Ehsan

Zitieren

APA

Iqbal, Y., Akhtar, T., Haroon, M., Mehmood, H., Nizami, T., Tahir, E., & Ehsan, M. (2023). 4-Adamantyl-(2-(arylidene)hydrazinyl)thiazoles As Potential Antidiabetic Agents: Experimental and Docking Studies. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2023-0010

Vancouver

Iqbal Y, Akhtar T, Haroon M, Mehmood H, Nizami T, Tahir E, et al. 4-Adamantyl-(2-(arylidene)hydrazinyl)thiazoles As Potential Antidiabetic Agents: Experimental and Docking Studies. Future Medicinal Chemistry. 2023. doi:10.4155/fmc-2023-0010

BibTeX
@article{Iqbal2023,
  author = {Iqbal, Yasir and Akhtar, Tashfeen and Haroon, Muhammad and Mehmood, Hasnain and Nizami, Tauqir and Tahir, Ehsaan and Ehsan, Muhammad},
  title = {4-Adamantyl-(2-(arylidene)hydrazinyl)thiazoles As Potential Antidiabetic Agents: Experimental and Docking Studies},
  journal = {Future Medicinal Chemistry},
  year = {2023},
  doi = {10.4155/fmc-2023-0010}
}
Kostenlos starten →